当前位置:首页 - 行情中心 - 傲农生物(603363) - 财务分析 - 现金流量表

傲农生物

(603363)

  

流通市值:56.46亿  总市值:71.83亿
流通股本:21.47亿   总股本:27.31亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金6,697,765,494.054,308,450,133.392,013,020,363.788,211,695,932.75
  收到其他与经营活动有关的现金342,374,488.55230,701,778.45130,701,853.32576,695,579.41
  经营活动现金流入小计7,040,139,982.64,539,151,911.842,143,722,217.18,788,391,512.16
  购买商品、接受劳务支付的现金6,233,294,511.464,154,633,637.271,929,360,176.417,145,739,982.74
  支付给职工以及为职工支付的现金552,022,360.56370,860,089.46189,022,954.1677,105,229.94
  支付的各项税费71,011,095.3537,243,301.8522,838,403.8978,815,324.57
  支付其他与经营活动有关的现金538,057,176.37305,032,429.76119,987,502.94733,787,562.15
  经营活动现金流出小计7,394,385,143.744,867,769,458.342,261,209,037.348,635,448,099.4
  经营活动产生的现金流量净额-354,245,161.14-328,617,546.5-117,486,820.24152,943,412.76
二、投资活动产生的现金流量:
  收回投资收到的现金548,583.06548,583.06548,583.066,171,387.07
  取得投资收益收到的现金13,867,367.265,687,940.973,611,529.233,041,275.59
  处置固定资产、无形资产和其他长期资产收回的现金净额1,584,693.781,175,944.6965,0964,692,305.3
  处置子公司及其他营业单位收到的现金净额2,409,018.11519,834.97-64,593,156.12
  收到的其他与投资活动有关的现金26,476,447.179,667,377.164,541,975.1614,494,260.27
  投资活动现金流入小计44,886,109.3817,599,680.769,667,183.4592,992,384.35
  购建固定资产、无形资产和其他长期资产支付的现金87,638,886.0467,517,399.4341,291,961.95229,897,677.94
  投资支付的现金260,000260,000200,00010,222,893.25
  取得子公司及其他营业单位支付的现金---389,574.83
  支付其他与投资活动有关的现金33,083,635.624,304,115.612,173,841.0323,530,816.28
  投资活动现金流出小计120,982,521.6492,081,515.0353,665,802.98264,040,962.3
  投资活动产生的现金流量净额-76,096,412.26-74,481,834.27-43,998,619.53-171,048,577.95
三、筹资活动产生的现金流量:
  吸收投资收到的现金277,528,600274,258,6003,860,20031,958,095.9
  其中:子公司吸收少数股东投资收到的现金8,518,6005,248,6003,860,20031,958,095.9
  取得借款收到的现金182,830,000118,880,000109,000,000297,125,642.83
  收到其他与筹资活动有关的现金62,950,631.2555,700,0001,700,00064,613,109.53
  筹资活动现金流入小计523,309,231.25448,838,600114,560,200393,696,848.26
  偿还债务支付的现金197,347,984.39117,942,603.0987,711,835.35519,825,408.66
  分配股利、利润或偿付利息支付的现金43,920,273.1227,822,104.7713,462,416.2106,971,694.47
  其中:子公司支付给少数股东的股利、利润26,373,325.0315,660,0007,850,00022,465,925.69
  支付其他与筹资活动有关的现金161,868,845.3135,517,884.6171,771,661.94333,648,316.63
  筹资活动现金流出小计403,137,102.81281,282,592.47172,945,913.49960,445,419.76
  筹资活动产生的现金流量净额120,172,128.44167,556,007.53-58,385,713.49-566,748,571.5
四、汇率变动对现金及现金等价物的影响-70,442.15-52,372.93-26,317.47-37,603.9
五、现金及现金等价物净增加额-310,239,887.11-235,595,746.17-219,897,470.73-584,891,340.59
  加:期初现金及现金等价物余额546,796,192.81546,796,192.81546,796,192.811,131,687,533.4
  期末现金及现金等价物余额236,556,305.7311,200,446.64326,898,722.08546,796,192.81
补充资料:
  净利润--271,700,904.73-89,408,894.36
  资产减值准备---60,942,041.88
  固定资产和投资性房地产折旧-197,508,000.91-396,957,149.95
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-197,508,000.91-396,957,149.95
  无形资产摊销-6,016,236-11,933,252.59
  长期待摊费用摊销-15,317,136.98-27,171,107.63
  处置固定资产、无形资产和其他长期资产的损失-2,355,027.41--359,130.85
  固定资产报废损失-3,745,317.84-3,581,324.26
  公允价值变动损失-580,430-161,130
  财务费用-55,182,758.52-146,889,568.05
  投资损失--42,134,455.95-28,421,393.24
  递延所得税-3,169,589.49--4,854,895.89
  其中:递延所得税资产减少-3,751,641.47--3,303,142.52
    递延所得税负债增加--582,051.98--1,551,753.37
  存货的减少--169,959,722.24--320,175,344.16
  经营性应收项目的减少--320,410,717.99--435,759,451.43
  经营性应付项目的增加-134,984,914.4--94,149,518.06
  其他-6,507.12--376,782.42
  债务转为资本-97,491,676.75-1,005,937,029.69
  不涉及现金收支的投资和筹资活动金额其他项目-70,999,115.81-79,456,694.41
  现金的期末余额-311,200,446.64-546,796,192.81
  减:现金的期初余额-546,796,192.81-1,131,687,533.4
  现金及现金等价物的净增加额--235,595,746.17--584,891,340.59
公告日期2026-10-302026-08-312026-04-282026-04-23
审计意见(境内)标准无保留意见
TOP↑